Provexis Share Discussion Threads

[johndee] 24/11/2016 15:00

A huge 1m plus delayed buy.

[someuwin] 24/11/2016 13:48

DSM are a massive company to have as a partner

20,000 employees. 10bn Valuation.

[wheelds] 24/11/2016 03:29

From the news:-
Promoting Fruitflow plus omega 3:-

"scientists at Provexis have extracted these ingredients and combined them with omega-3 in capsule that has been classified as a food. Experts said for at least six weeks, the supplement will work to promote normal blood flow and normal heart function."

All looking good.IMHO
Last time collaboration with Coca Cola the share price rose to 15p/20p before Coca Cola pulled out and share price fell to ridiculously low levels like 0.25p but now back on track with Chinese collaboration deal and latest news, and I can not see the Chinese pulling out or DSM pulling out with their Omega 3 now combined with our Fruitflow.

.

[wheelds] 23/11/2016 16:31

News out today on Aspirin verus Fruitflow tests:- That's on top of the China Collaboration deal; so all looking good and being reported in the press. So all good for share price rise:
And you never know, last time on news of Collaboration between Coca Cola on top of good news like this, shares price rose to 15p/20p before Coca Cola pulled out and share price fell;
But this time I can't see the Chinese pulling out and the medical profession ignoring the aspirin - Fruitflow results this time around.

"The study findings are significant and serve to demonstrate the potential effectiveness of Fruitflow® as a dietary supplement with a significant effect on blood flow, suitable for daily use in primary prevention of CVD, and with no adverse side effects."

"The World Health Organization reports that more people die annually from CVDs than from any other cause¹ and the global market for cardiovascular disease, to include dietary supplements, is estimated to be in excess of $10 billion per year."

"The US FDA states that after carefully examining scientific data from major studies, it has concluded 'the data do not support the use of aspirin as a preventive medication by people who have not had a heart attack, stroke or cardiovascular problems, a use that is called 'primary prevention.' In such people, the benefit has not been established but risks - such as dangerous bleeding into the brain or stomach - are still present.' ²

[davidlloyd] 23/11/2016 13:53

More important in my view is that the website is up and running, there is the fruitflow omega 3 product on sale, and sales on the back of such articles should go straight to the bottom line (I hope :-) )
This wasn't the case in 2010.....
DL

[bareknee] 23/11/2016 11:53

Guns

Yea, it'll have been peer reviewed prior to publication, but the results were accepted by the EFSA so it already had a bigger tick in the box !

Edit : Actually the aspirin trail was after the EFSA claim so wtfdik

The FDA quote is just good marketing and will help in two ways. Firstly it will help get the message across to consumers, but equally, and possibly more so, it's aimed at investors who might then support future funding requirements for further BP trials and expanding the FF+ product.

Don't get me wrong mate, I ain't complaining, the board should have been doing these things years ago, but better late than never. But though the cynic / realist in me knows how the market works, the pragmatist in me is happy to run in tandem with it.

BB

[gunsofmarscapone] 23/11/2016 11:37

Bareknee, ticked you up as you are clearly an honest person.

[fender] 23/11/2016 11:36

According to the Express :- "The study was published today in the European Journal of Clinical Nutrition."

[gunsofmarscapone] 23/11/2016 11:35

Irrelevant Bareknee, and not entirely correct.

At academic and regulatory level no information can be considered valid until all due diligence including full peer appraisal and critique is complete. Then for a ministry as authorative as the FDA to issue the following statement;

"The US FDA states that after carefully examining scientific data from major studies, it has concluded 'the data do not support the use of aspirin as a preventive medication by people who have not had a heart attack, stroke or cardiovascular problems, a use that is called 'primary prevention.' In such people, the benefit has not been established but risks - such as dangerous bleeding into the brain or stomach - are still present.' ²

requires complete medico-legal oversight. Of course what Provexis, investors, the population etc can infer is that Fruitflow(tm) is probably the leading alternative for a HEALTHY person to MAINTAIN and probably IMPROVE their health.

Of course this is purely my own opinion of the relevance of todays news; what is a greater priority for most PI's whose emotions blow in the wind, from being slightly less anxious when the share price rises to indicting the board when the share price lowers a bit. The best way imvho is to try and figure out which way the wind is blowing and have the balls to go steaming in when the share price is languishing. Atb Guns

[bareknee] 23/11/2016 11:33

Nice article in The Express



Fair play to the board. For something which is actually old news they're getting the message out there. The cynic in me wonders if this is partly being done to favour those who supported the placing, but we shouldn't look a gift horse in the mouth

Have to admit, I think the fact that today's RNS fails to mention the trial was carried out in 2010 is a bit naughty, but heh ho, such is life.

BB

[bareknee] 23/11/2016 11:00

Guns

You do know this RNS is about the publication of a trial from 2010 don't you ?

There"s some lovely subtle ramping being carried out over on the LSE board. Long may it continue !

BB

[gunsofmarscapone] 23/11/2016 10:14

HUGE NEWS TODAY

The worlds first completely safe alternative to aspirin. Aspirin can cause strokes and potentially fatal gastric bleeds. Therefore aspirin is only used in patients who are trying to balance catastrophic risks.

THIS IS A MASSIVE RNS!

I continue to accumulate on a weeky basis and expect to RETIRE on the profits......

[lafin] 19/11/2016 19:29

LibraG,
Define "strategic relationship"in this context.
And don't make assumptions based on nothing but your imagination.

wheelds , shhhh you are overdoing it.

[wheelds] 19/11/2016 18:14

In the global market;-
Once the word gets around that China is now planning to regulate and produce Fruitflow products to help manage the ever increasing number of ill health heart related problems caused by bad blood flow, competition to produce/sell more and more Fruitflow products around the global market will increase. IMHO

And soon we will have confirmation that our Fruitflow can be used to manage blood pressure.

All looking good.

[wheelds] 19/11/2016 17:31

News about the DSM/Provexis/Fruitflow/China deal:-

Clearly states:- "and testing procedures to accord with Chinese technical and regulatory standards"

This is all about our Fruitflow becoming available in China via new products produced in China relative to their health standard regulations..

"DSM Nutritional Products ("DSM"), has entered into a strategic collaboration agreement for Fruitflow® with BY-HEALTH Co., Ltd ("BY-HEALTH"), a substantial listed Chinese dietary supplement business."

"The strategic collaboration agreement between DSM and BY-HEALTH will focus on the development of new products that contribute to cardiovascular health, to include the establishment of relevant evaluation and testing procedures to accord with Chinese technical and regulatory standards"

[lafin] 19/11/2016 13:33

Or may be of some significance.

No way of knowing.

[lafin] 19/11/2016 13:32

Fruitflow was approved to be sold in China years ago.
No idea if any has been so far.
My point is this is nothing really new and may be of little significance.

[hope67] 18/11/2016 18:30

Post from Gixer on iii



Its not just about 1 product for By-Health.
Its about research and development of Fruitflow (products for the Chinese market. (and maybe others)

"Tomson times on November 17 announced cooperation in the life sciences with a leading position in the Dutch DSM Group to conduct a joint research and development of new product features cardiovascular health. The R & D cooperation will be "light network element" (Fruitflow) as the main direction of development of new features contribute to cardiovascular health products, and establish the relevant evaluation methods and detection methods, as well as in line with national standards of the new functional evaluation technology system ."
hxxp://health.gmw.cn/2016-11/17/content_23012151.htm

"The first work on this new health agreement, the two sides will be the first to ratify the European Food Safety Authority
can feed "light network element." (Fruitflow.) Direction for the development of cooperation, contribute to the development of new cardiovascular health
functional products. "

"
The company reached with DSM Innovation strategic partnership, the two sides committed to the joint development of functional ingredients, functional dietary supplements in China's scientific research and application, jointly developed based on the "light network element." (Fruitflow.) Heart new blood vessels healthy, active distribution of new functional areas of health food,"
hxxp://www.cfi.net.cn/p20161117001390.html

"The strategic collaboration agreement between DSM and BY-HEALTH will focus on the development of new products that contribute to cardiovascular health, to include the establishment of relevant evaluation and testing procedures to accord with Chinese technical and regulatory standards.

The development process will target the creation of new products for people who are at risk of cardiovascular disease, particularly to include those over 40 years of age."

[wheelds] 18/11/2016 16:25

Same as last time; when good news of partnership with Coca Cola and the share price rose and fell and rose and fell and over the year rose from 0.6p to around 15p-22p before Coca Cola pulled out after the end of the year.
So, in my opinion the share price will rise and fall but over the year will be much higher then today; - Last time when it got to 5p it then dropped to 3p and the rose again to 8p etc. etc.

We have a great product with Fruitflow and as the good Chinese news spreads around the globe you will get other large companies in America etc. seeing this as a challenge to their health products and will try to also get a trade deal/partnership deal going with DSM and Provexis for our Fruitflow. IMHO

[twodegrees] 18/11/2016 16:18

librag thank you...fair point

[librag] 18/11/2016 16:16

133M shares traded = around 12% of shares in circulation.
With delayed reporting and balancing by MMs I'm not sure you can rely on buy:sell reporting.

[twodegrees] 18/11/2016 16:08

surely the closing price is going to fall. many trades this afternoon showing as sells but MM's have not moved the price... any thoughts anyone